Key Details
Price
$3.95Annual ROE
201.12%Beta
-4.46Events Calendar
Next earnings date:
Mar 18, 2025Recent quarterly earnings:
Jun 14, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Jan 29, 2025Analyst ratings
Recent major analysts updates
Dec 12, 24 HC Wainwright & Co.
BuyDec 3, 24 HC Wainwright & Co.
BuyOct 3, 24 HC Wainwright & Co.
BuySep 19, 24 HC Wainwright & Co.
BuySep 11, 24 HC Wainwright & Co.
BuyJun 4, 24 HC Wainwright & Co.
BuyMay 24, 24 HC Wainwright & Co.
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
BriaCell Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
BriaCell Therapeutics: High-Potential In Phase 3 Metastatic Breast Cancer, But Financing Concerns
BCTX
seekingalpha.comOctober 22, 2024
BriaCell Therapeutics' lead candidate, Bria-IMT, shows promising trial results for metastatic breast cancer, potentially doubling overall survival and median progression-free survival. Despite a market cap below $30 million, BriaCell could tap into a $1-$5 billion market upon approval, with valuations between $1-$2 billion. Financing and shareholder dilution remain significant concerns, with recent offerings raising $18.5 million but also massively increasing the share count.
What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock
BCTX
zacks.comSeptember 27, 2024
BRIACELL THERAP (BCTX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday
BCTX
benzinga.comSeptember 11, 2024
On Wednesday, BriaCell Therapeutics BCTX stock traded higher with a session volume of 113.08 million, compared to the average volume of 366.19 thousand, according to data from Benzinga Pro.
FAQ
- What is the ticker symbol for BriaCell Therapeutics?
- Does BriaCell Therapeutics pay dividends?
- What sector is BriaCell Therapeutics in?
- What industry is BriaCell Therapeutics in?
- What country is BriaCell Therapeutics based in?
- When did BriaCell Therapeutics go public?
- Is BriaCell Therapeutics in the S&P 500?
- Is BriaCell Therapeutics in the NASDAQ 100?
- Is BriaCell Therapeutics in the Dow Jones?
- When was BriaCell Therapeutics's last earnings report?
- When does BriaCell Therapeutics report earnings?
- Should I buy BriaCell Therapeutics stock now?
What is the ticker symbol for BriaCell Therapeutics?
The ticker symbol for BriaCell Therapeutics is NASDAQ:BCTX
Does BriaCell Therapeutics pay dividends?
No, BriaCell Therapeutics does not pay dividends
What sector is BriaCell Therapeutics in?
BriaCell Therapeutics is in the Healthcare sector
What industry is BriaCell Therapeutics in?
BriaCell Therapeutics is in the Biotechnology industry
What country is BriaCell Therapeutics based in?
BriaCell Therapeutics is headquartered in Canada
When did BriaCell Therapeutics go public?
BriaCell Therapeutics's initial public offering (IPO) was on March 14, 2012
Is BriaCell Therapeutics in the S&P 500?
No, BriaCell Therapeutics is not included in the S&P 500 index
Is BriaCell Therapeutics in the NASDAQ 100?
No, BriaCell Therapeutics is not included in the NASDAQ 100 index
Is BriaCell Therapeutics in the Dow Jones?
No, BriaCell Therapeutics is not included in the Dow Jones index
When was BriaCell Therapeutics's last earnings report?
BriaCell Therapeutics's most recent earnings report was on Jun 14, 2024
When does BriaCell Therapeutics report earnings?
The next expected earnings date for BriaCell Therapeutics is Mar 18, 2025
Should I buy BriaCell Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions